Antiarrhythmic Properties of a Prior Oral Loading of Amiodarone in In Vivo Canine Coronary Ligation/Reperfusion-Induced Arrhythmia Model: Comparison With Other Class III Antiarrhythmic Drugs
Amiodarone, which is generally classified as class III antiarrhythmic drug in the Vaughan Williams classification, is widely used for the treatments of refractory arrhythmias. However, we previously reported that intravenous infusion of amiodarone (6.67 mg/kg per hour) did not suppress arrhythmias i...
Main Authors: | Yoshinobu Nagasawa, Jianguang Chen, Keitaro Hashimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319322510 |
Similar Items
-
Arrhythmia Models for Drug Research: Classification of Antiarrhythmic Drugs
by: Keitaro Hashimoto
Published: (2007-01-01) -
SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
by: N P Dorofeeva, et al.
Published: (2017-03-01) -
Hemodynamic and antiarrhythmic effects of lidocaine or amiodarone in dogs anesthetized with halothane
by: J.V. Moro, et al.
Published: (2013-08-01) -
Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
by: Joanne J. A. van Bavel, et al.
Published: (2018-02-01) -
Amiodarone and thyroid: “The Victim and its Executioner” implications of the antiarrhythmic on thyroid disfunctions
by: João Carlos Ramos-Dias, et al.
Published: (2011-03-01)